XIth Eurasian Hematology-Oncology Congress - EHOC 2020
IO for R/R cHL: Optimal Treatment Regimen, Therapy Duration & Discontinuation, Prognostic Factors, Treatment Strategy in Case of Resistance
Login to view comments.
Click here to Login